30 July 2020
Visiongain has launched a new report Poultry Diagnostics Market Report 2020-2030: Forecasts by Test (ELISA, PCR, Other Diagnostic Tests), by Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Avian Pasteurellosis, Infectious Bronchitis, Infectious Bursal Disease, Avian Encephalomyelitis, Avian Reovirus, Chicken Anemia), and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.
Poultry diagnostics are mainly used by owners who have poultry farms, where the birds such as ducks, chicken, and turkey are nurtured and domesticated. Poultry diagnostics are usually conducted to avoid any poultry disease outbreak that are caused by bacteria, virus, and fungi. Avian Influenza is the dominant segment in the poultry diagnostics market owing to the frequent influenza outbreak, especially in African and South Asian countries. Some of the common symptoms in birds affected by this disease are subclinical infection, decrease in egg production, and respiratory diseases. Such disease negatively affects the poultry market, leading to financial losses.
Researchers and clinicians from various veterinary centers can share information regarding the current ongoing developments in the field of diagnostics, preventive measures, and treatments available for birds. Thus, the increase in disease outbreak in birds, the rise in incidence of zoonotic diseases and increasing awareness regarding the importance of poultry diagnostics are a major factor driving the poultry diagnostics market.
Owing to the increase in the global population and large number of undernourished population, the government have taken initiative to promote animal health products. According to the International Fund for Agricultural Development, there are over 795 million undernourished people globally. Products such as eggs and meat obtained from poultry farms are protein rich food, which can contribute to nourish the increasing global population. Thus, there is need for larger food supply of animal products. The increased demand for protein-rich food and increasing purchasing power further drives the growth of global poultry diagnostics market. However, the high cost of poultry production and lack of awareness are expected to hamper the market growth.
The Visiongain report analyst commented “Many companies are trying to increase the awareness regarding the importance of poultry diagnostics. In order to increase the awareness of the farmers, animal health information portals have also been launched in some developed countries. The rise in incidence of zoonotic disease, increase in poultry disease outbreaks, and growing demand for protein-rich food are boosting the growth of the poultry diagnostics market.”
The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include Zoetis, Qiagen, IDvet, BioChek Smart Veterinary Diagnostics, Bioneer Corporation, Thermo Fisher Scientific Inc., Biogenetics Biotechnology Company, Megacor Diagnostik GmbH, Idexx Laboratories, Inc., and FinTech, Ltd.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.
12 April 2021
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.
09 April 2021
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.
06 April 2021
Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.